Infrared thermography (IRT) measures the heat emitted from a surface, displays that information as a pictorial representation called a thermogram, and is capable of being a remote, noninvasive technology that provides information on the health of an animal. Foot-and-mouth disease (FMD) caused by FMD virus (FMDV) is a severe, highly communicable viral disease of cloven-hoofed animals, including both domestic and wild ruminants. Early detection of the disease may reduce economic loss and loss of susceptible wildlife. The objective of this study was to evaluate the use of IRT to detect possible heat changes associated with sites of infection with FMDV in experimentally infected mule deer (Odocoileus hemionus). Infection occurred through either inoculation with FMDV or exposure to inoculated animals. Early vesicular lesions were observed on the mouth, feet, or both within 24 hrs postinoculation and 48-96 hrs post-exposure. From internal temperature sensors, the exposed animals' body temperatures elevated significantly from the pre-infection temperature (38.8uC, P # 0.002) starting the day before any lesions were observed. Body temperature was also found not to be significantly different from eye temperatures of well-focused thermograms. For feet thermograms, the mean of the daily maximum (MMAX) foot temperature rose significantly (P 5 0.017) from two days before (27.3uC 6 1.9uC SE) to the maximum MMAX observed (33.0uC 6 2.0uC SE) at two days after the first foot lesion occurrence. These observed changes indicate that IRT may be a rapid, remote, and noninvasive method to screen for suspect animals in order to test further for FMDV infection during an FMD outbreak.
ABSTRACT:In 2011, we conducted a field trial in rural West Virginia, USA to evaluate the safety and immunogenicity of a live, recombinant human adenovirus (AdRG1.3) rabies virus glycoprotein vaccine (Ontario Rabies Vaccine Bait; ONRAB) in wild raccoons (Procyon lotor) and striped skunks (Mephitis mephitis). We selected ONRAB for evaluation because of its effectiveness in raccoon rabies management in Ontario and Quebec, Canada, and significantly higher antibody prevalence rates in raccoons compared with a recombinant vaccinia-rabies glycoprotein (V-RG) vaccine, Raboral V-RGH, in US-Canada border studies. Raccoon rabies was enzootic and oral rabies vaccination (ORV) had never been used in the study area. We distributed 79,027 ONRAB baits at 75 baits/km 2 mostly by fixed-wing aircraft along parallel flight lines at 750-m intervals. Antibody prevalence was significantly higher at 49.2% (n5262) in raccoons after ONRAB was distributed than the 9.6% (n5395) before ORV. This was the highest antibody prevalence observed in raccoons by US Department of Agriculture Wildlife Services for areas with similar management histories evaluated before and after an initial ORV campaign at 75 baits/km 2 with Raboral V-RG. Tetracycline biomarker (TTCC) was significantly higher among antibodypositive raccoons after ONRAB baiting and was similar among raccoons before ORV had been conducted, an indication of vaccine-induced rabies virus-neutralizing antibody production following consumption of bait containing TTCC. Skunk sample size was inadequate to assess ONRAB effects. Safety and immunogenicity results supported replication of this field trial and led to a recommendation for expanded field trials in 2012 to evaluate safety and immunogenicity of ground-distributed ONRAB at 150 baits/km 2 in residential and commercial habitats in Ohio, USA and aerially distributed ONRAB at 75 baits/km 2 in rural habitats along US-Quebec border.
The small Indian mongoose (Herpestes auropunctatus) is an invasive species and rabies reservoir in Puerto Rico. In the continental United States, terrestrial wildlife rabies is primarily managed by the National Rabies Management Program (NRMP) of the United States Department of Agriculture through oral rabies vaccination (ORV); the distribution of the vaccine baits is influenced by the population density of the target species. The NRMP uses a density index for estimating raccoon (Procyon lotor) population density to guide bait distribution. In Puerto Rico, a wildlife rabies vaccination program does not exist and vaccination of domestic animals is limited and not compulsory. To acquire information on density and other population dynamics, we compared a mongoose density index (MDI) adapted from the NRMP raccoon density index (RDI) to 3 other methods (2 types of capture-mark-recapture [CAPTURE and MARK] and spatially explicit capture-recapture [SECR]) for estimating density that incorporate modeling procedures on detection probabilities, and examined the spatial distribution of mongooses within our study plots. We used the RDI trapping protocol modified for mongooses to livetrap mongooses in El Yunque National Forest (El Yunque) and Cabo Rojo National Wildlife Refuge (Cabo Rojo) in fall of 2011 and spring of 2012 resulting in 4 trapping sessions. The MDI estimates were consistently less than those from other methods for estimating mongoose densities. The MDI detected a greater mongoose density during the wet season (0.55 mongooses/ha) than the dry season (0.34 mongooses/ha) at Cabo Rojo, consistent with all 3 other density estimation methods. Overall, the correlation coefficient between MDI and the other calculation methods was !0.68. When we examined known locations of mongooses and travel distances, we detected more mongooses in a smaller area within the study plot at Cabo Rojo than at El Yunque. The MDI provided information on the spatial distribution of mongooses, which will be needed to implement an ORV program to target mongooses in Puerto Rico. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.